Morbidity and mortality associated with arterial surgery site infections by resistant microorganisms Morbimortalidade relacionada às infecções de ferida operatória ocasionadas por micro-organismos resistentes em cirurgias arteriais

Background: Surgical site infection is a severe complication of peripheral vascular surgery with high morbidity and mortality rates. Objective: To evaluate the morbidity and mortality of infections of peripheral artery surgery sites caused by resistant microorganisms. Methods: This was a prospective study of a cohort of patients who underwent peripheral artery revascularization procedures and developed surgical site infections between March 2007 and March 2011. Results: Mean age was 63.7 years; males accounted for 64.3% of all cases. The overall prevalence of bacterial resistance to antimicrobials was 65.7%. The most common microorganism identified was Staphylococcus aureus (30%). Comparison of the demographic and surgical characteristics of both subsets (resistant versus non-resistant) detected a significant difference in length of preoperative hospital stay (9.3 days vs. 3.7 days). The subset of patients with infections by resistant microorganisms had higher rates of reoperation, lower numbers of limb amputations and lower mortality, but the differences compared to the subset without resistant infections were not significant. Long-term survival was similar. Conclusions: This study detected no statistically significant differences in morbidity or mortality between subsets with surgical wound infections caused by resistant and not-resistant microorganisms.

[1]  J. R. R. Timi Estudo bacteriologico da placa aterosclerotica da arteria femoral , 2013 .

[2]  M. Lucas,et al.  Profilaxia antimicrobiana em cirurgia vascular periférica: cefalosporina ainda é o padrão-ouro? , 2007 .

[3]  D. Sahm,et al.  Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States , 2006, Annals of Clinical Microbiology and Antimicrobials.

[4]  Y. Hsiang,et al.  Nosocomial MRSA Infection in Vascular Surgery Patients: Impact on Patient Outcome , 2005, Vascular and endovascular surgery.

[5]  Sung-Han Kim,et al.  Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome , 2004, Antimicrobial Agents and Chemotherapy.

[6]  L. Napolitano,et al.  Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. , 2004, Surgical infections.

[7]  B. Lal,et al.  Methicillin-resistant Staphylococcus aureus Infection Does Not Adversely Affect Clinical Outcome of Lower Extremity Amputations , 2003, Annals of vascular surgery.

[8]  T. Bonamigo,et al.  Use of Superficial Femoral Vein in the Treatment of Infected Aortoiliofemoral Prosthetic Grafts , 2002, Cardiovascular surgery.

[9]  P. Hayes,et al.  A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  H. Chambers,et al.  The changing epidemiology of Staphylococcus aureus? , 2001, Emerging infectious diseases.

[11]  J. Mcgowan Economic impact of antimicrobial resistance. , 2001, Emerging infectious diseases.

[12]  J. Degener,et al.  Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. , 1999, The Journal of hospital infection.

[13]  R. Galland,et al.  Surgical patients with methicillin resistant staphylococcus aureus infection: an analysis of outcome using P-POSSUM. , 1999, Journal of the Royal College of Surgeons of Edinburgh.

[14]  R. Greenhalgh,et al.  The pathogenesis of vascular graft infection. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  D. Bandyk,et al.  Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states. , 1993, Journal of vascular surgery.

[16]  G. Seabrook,et al.  Wound complications of the in situ saphenous vein bypass technique. , 1992, Journal of vascular surgery.

[17]  C. Edmiston,et al.  Sequential analysis of staphylococcal colonization of body surfaces of patients undergoing vascular surgery , 1990, Journal of clinical microbiology.

[18]  D. Heitjan,et al.  Wound complications of autogenous subcutaneous infrainguinal arterial bypass surgery: predisposing factors and management. , 1990, Journal of vascular surgery.

[19]  D. Bandyk,et al.  Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. , 1989, Journal of vascular surgery.

[20]  R. Howard,et al.  Surgical Infectious Diseases , 1982 .

[21]  P. Cruse,et al.  The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. , 1980, The Surgical clinics of North America.

[22]  J. P. Elliott,et al.  Infection in Arterial Reconstruction with Synthetic Grafts , 1972, Annals of surgery.

[23]  Linton Rr The prophylactic use of the antibiotics in clean surgery. , 1961 .